Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 9/20 | 0.72 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.72 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.72 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.72 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.72 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.72 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.72 |
| ▸ | DRD2 | P14416 | 1/20 | 0.72 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.72 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.72 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.72 |
| ▸ | MAOA | P21397 | 1/20 | 0.72 |
| ▸ | DRD4 | P21917 | 1/20 | 0.72 |
| ▸ | MAOB | P27338 | 1/20 | 0.72 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.72 |
| ▸ | HRH1 | P35367 | 1/20 | 0.72 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.72 |
| ▸ | DRD3 | P35462 | 1/20 | 0.72 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.72 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20926854 | 0.88 | OPRM1 (0.71) | OPRM1OPRD1SIGMAR1SLC22A1NR1I2 | |
| SCHEMBL23823806 | 0.87 | OPRM1 (0.79) | OPRM1OPRD1SIGMAR1SLC22A1NR1I2 | |
| SCHEMBL14252397 | 0.87 | OPRM1 (0.70) | OPRM1OPRD1SIGMAR1SLC22A1NR1I2 | |
| SCHEMBL23651692 | 0.87 | OPRM1 (0.78) | OPRM1OPRD1SIGMAR1SLC22A1NR1I2 | |
| SCHEMBL13116886 | 0.87 | OPRM1 (0.70) | OPRM1OPRD1SIGMAR1SLC22A1NR1I2 | |
| SCHEMBL8565516 | 0.86 | OPRM1 (0.77) | OPRM1OPRD1SIGMAR1SLC22A1NR1I2 | |
| SCHEMBL23651683 | 0.86 | OPRM1 (0.76) | OPRM1OPRD1SIGMAR1SLC22A1NR1I2 | |
| SCHEMBL20916018 | 0.86 | OPRM1 (0.68) | OPRM1OPRD1SIGMAR1SLC22A1NR1I2 | |
| SCHEMBL24801394 | 0.85 | OPRM1 (0.76) | OPRM1OPRD1SIGMAR1SLC22A1NR1I2 | |
| SCHEMBL8831680 | 0.85 | OPRM1 (0.76) | OPRM1OPRD1SIGMAR1SLC22A1NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036595-A | Fentanyl hapten, complete antigen thereof and application thereof | 中国药科大学 | 2026-05-15 | — | — | CN | claimed |
| CN-119291192-A | Kit for detecting content of fentanyl and analogues thereof and application of kit | 中国药科大学 | 2025-01-10 | — | — | CN | claimed |
| CN-122036595-A | Fentanyl hapten, complete antigen thereof and application thereof | 中国药科大学 | 2026-05-15 | — | — | CN | disclosed |
| WO-2025094145-A1 | INTEGRATED SINGLE USE TEST KITS FOR DRUG CHECKING | ENOCIAL AKTIEBOLAG (SE) | 2025-05-08 | — | — | WO | disclosed |
| US-20140179686-A1 | Novel Vanilloid Receptor Ligands and Use Thereof for the Production of Pharmaceutical Preparations | GRUENENTHAL GMBH (DE) | 2014-06-26 | — | — | US | disclosed |
| US-8710233-B2 | Vanilloid receptor ligands and use thereof for the production of pharmaceutical preparations | GRUENENTHAL GMBH (DE) | 2014-04-29 | — | — | US | disclosed |
| US-20100273765-A1 | Rifamycin analogs and uses thereof | ACTIVBIOTICS, INC. | 2010-10-28 | — | — | US | disclosed |
| CN-100402084-C | Method for detection or quantitative determination of metabolite of fentanyl or metabolite of fentanyl analogues and kit | LANDAUKES LAB CO LTD (GB) | 2008-07-16 | — | — | CN | disclosed |
| US-7271165-B2 | Rifamycin analogs and uses thereof | ACTIVBIOTICS, INC. (US) | 2007-09-18 | — | — | US | disclosed |
| US-20070142392-A1 | Uses of rifamycins | ACTIVBIOTICS, INC. (US) | 2007-06-21 | — | — | US | disclosed |
| US-20070105861-A1 | NOVEL VANILLOID RECEPTOR LIGANDS AND USE THEREOF FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS | GRUENENTHAL GMBH (DE) | 2007-05-10 | — | — | US | disclosed |
| EP-1312923-B1 | Method and kit for detecting, or determining the quantity of, metabolites of fentanyl and metabolites of fentanyl analogs | RANDOX LAB LTD (GB) | 2007-03-28 | — | — | EP | disclosed |
| US-7109310-B2 | Method and kit for detecting, or determining the quantity of, metabolites of fentanyl and metabolites of fentanyl analogs | RANDOX LABORATORIES, LTD. (IE) | 2006-09-19 | — | — | US | disclosed |
| US-20030170728-A1 | Method and kit for detecting, or determining the quantity of, metabolites of fentanyl and metabolites of fentanyl analogs | RANDOX LABORATORIES LIMITED | 2003-09-11 | — | — | US | disclosed |
| CN-1428607-A | Method for detection or quantitative determination of metabolite of fentanyl or metabolite of fentanyl analogues and kit | LANDAUKES LAB CO LTD (GB) | 2003-07-09 | — | — | CN | disclosed |
| EP-1312923-A2 | Method and kit for detecting, or determining the quantity of, metabolites of fentanyl and metabolites of fentanyl analogs | Randox Laboratories Ltd. (GB) | 2003-05-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070105861-A1 | NOVEL VANILLOID RECEPTOR LIGANDS AND USE THEREOF FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS | TRPV1, TRPV5, TRPV2 | OPRM1 137/4885OPRD1 97/4885SIGMAR1 180/4885 |
| US-20070142392-A1 | Uses of rifamycins | TNF, TLR6, IL6 | OPRM1 2041/4885OPRD1 2983/4885SIGMAR1 1528/4885 |
| US-20100273765-A1 | Rifamycin analogs and uses thereof | RIF1, HDAC5, AADAC | OPRM1 3207/4885OPRD1 3678/4885SIGMAR1 2370/4885 |
| US-20030170728-A1 | Method and kit for detecting, or determining the quantity of, metabolites of fentanyl and metabolites of fentanyl analogs | OPRK1, KIT, OPRM1 | OPRM1 3/4885OPRD1 14/4885SIGMAR1 262/4885 |
| US-20140179686-A1 | Novel Vanilloid Receptor Ligands and Use Thereof for the Production of Pharmaceutical Preparations | TRPV1, TRPV5, TRPV2 | OPRM1 137/4885OPRD1 97/4885SIGMAR1 180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.